Resistance patterns to anti-PD-1 therapy in metastatic melanoma
Year: 2016
Type: editorial
Abstract: Anti-PD-1 antibodies block the immune checkpoint programmed death 1 receptor to increase T cell specific anti-tumor responses (1,2).
Source: Chinese Clinical Oncology
Institutions: University of South Florida, Moffitt Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
Funder: National Cancer Institute
OpenAlex ID: W2516563891
